Urology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Prieto FJT et al. – Cinacalcet was effective in the management of posttransplant persistent secondary hyperparathyroidism, resulting in decreased calcemia and iPTH, while also improving femoral neck bone loss. Longer–term studies with control groups are needed to determine the drug's influence on overall bone mineral density.

Related Articles

Postexercise Cardiac Performance Among Patients With Mild Primary Hyperparathyroidism
The Endocrinologist, 11/16/09    Relevance Score: 87%

Insulin resistance is not coupled with defective insulin secretion in primary hyperparathyroidism
Diabetic Medicine, 10/02/09    Relevance Score: 87%

Multimodality imaging in hyperparathyroidism
Postgraduate Medical Journal, 11/10/09    Relevance Score: 85%

No recurrence of sporadic primary hyperparathyroidism when cure is established 6 months after parathyroidectomy
European Journal of Endocrinology, 11/05/09    Relevance Score: 85%

What steps should be considered in the patient who has had a negative cervical exploration for primary hyperparathyroidism
Clinical Endocrinology, 10/15/09    Relevance Score: 84%

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address